Eva Renee Barnett
2023
In 2023, Eva Renee Barnett earned a total compensation of $2.1M as Chief Financial Officer at Immunovant, a 53% decrease compared to previous year.
Compensation breakdown
| Bonus | $414,430 |
|---|---|
| Option Awards | $636,078 |
| Salary | $435,000 |
| Stock Awards | $562,952 |
| Other | $21,635 |
| Total | $2,070,095 |
Barnett received $636.1K in option awards, accounting for 31% of the total pay in 2023.
Barnett also received $414.4K in bonus, $435K in salary, $563K in stock awards and $21.6K in other compensation.
Rankings
In 2023, Eva Renee Barnett's compensation ranked 485th out of 2,647 executives tracked by ExecPay. In other words, Barnett earned more than 81.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 485 out of 2,647 | 82nd |
Division Manufacturing | 279 out of 1,447 | 81st |
Major group Chemicals And Allied Products | 194 out of 817 | 76th |
Industry group Drugs | 191 out of 783 | 76th |
Industry Biological Products, Except Diagnostic Substances | 68 out of 204 | 67th |
Source: SEC filing on June 26, 2023.
Barnett's colleagues
We found two more compensation records of executives who worked with Eva Renee Barnett at Immunovant in 2023.